Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page:
About CDC.gov

United States, Advisory Committee on Immunization Practices. ;
Centers for Disease Control and Prevention (U.S.) ;
Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Science. ;
...
More ▼

United States, Advisory Committee on Immunization Practices. ;
Centers for Disease Control and Prevention (U.S.) ;
Centers for Disease Control and Prevention (U.S.), Office of the Associate Director for Science. ;
National Center for Immunization and Respiratory Diseases (U.S.) ;
National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division. ;
National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division. ;
National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion., Immunization Safety Office. Less ▲

"This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and CDC. Use of influenza A (H1N1) 2009 monovalent vaccine--recommendations of the Advisory Committee on Immunization Practices [ACIP], 2009. MMWR 2009;58:[No. RR-10]). The 2010 influenza recommendations include new and updated information. Highlights of the 2010 recommendations include 1) a recommendation that annual vaccination be administered to all persons aged >̲6 months for the 2010-11 influenza season; 2) a recommendation that children aged 6 months-8 years whose vaccination status is unknown or who have never received seasonal influenza vaccine before (or who received seasonal vaccine for the first time in 2009-10 but received only 1 dose in their first year of vaccination) as well as children who did not receive at least 1 dose of an influenza A (H1N1) 2009 monovalent vaccine regardless of previous influenza vaccine history should receive 2 doses of a 2010-11 seasonal influenza vaccine (minimum interval: 4 weeks) during the 2010-11 season; 3) a recommendation that vaccines containing the 2010-11 trivalent vaccine virus strains A/California/7/2009 (H1N1)-like (the same strain as was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; 4) information about Fluzone High-Dose, a newly approved vaccine for persons aged >65 years; and 5) information about other standard-dose newly approved influenza vaccines and previously approved vaccines with expanded age indications. Vaccination efforts should begin as soon as the 2010-11 seasonal influenza vaccine is available and continue through the influenza season. These recommendations also include a summary of safety data for U.S.-licensed influenza vaccines. These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates or supplements that might be required during the 2010-11 influenza season also will be available at this website. Recommendations for influenza diagnosis and antiviral use will be published before the start of the 2010-11 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information." - p 1.

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division.; National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division.;

This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommend...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;This report updates the 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory C...

United States, Advisory Committee on Immunization Practices.; National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States...

National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.; United States, Advisory Committee on Immunization Practices.;

This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a) the age ...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

"These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1996-97 influenza season (superseding MMWR 1995;44(No. RR-3):1-22). The principal changes include information about a) t...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

&quot;This report updates the 2000 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 2000;49[No. RR-3]:1-38). The 2001 recommendations include new or updated info...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.;

&quot;This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;These recommendations update information concerning the vaccine and antiviral agents available for controlling influenza during the 1997-98 influenza season (superseding MMWR 1996;45[No. RR-5]:1-24). The principal changes include informatio...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;This report updates 1998 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1998;47[No. RR-6]:1-26). The principal changes include a) information on the infl...

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes in...

&amp;quot;This report updates the 2007 recommendations by CDC&amp;apos;s Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendation...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division.;

&quot;This report updates the 2006 recommendations by CDC&apos;s Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.), Immunization Services Division.; National Center for Immunization and Respiratory Diseases (U.S.), Influenza Division.;

This report updates the 2008 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of seasonal influenza (CDC. Prevention and control of influenza: recommend...

This document provides updated guidance for the use of influenza vaccines in the United States for the 2011-12 influenza season. In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all p...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

"These recommendations update information on the vaccine available for controlling influenza during the 1993-94 influenza season (superseding MMWR 1992;41(No. RR-9):1-17.) The principal changes include information about a) the influenza strains ...

United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Infectious Diseases (U.S.), Division of Viral and Rickettsial Diseases.;

&quot;These recommendations update information on the vaccine available for controlling influenza during the 1994-95 influenza season. The recommendations supersede MMWR 1993;42(No. RR-6)1-13. Antiviral agents also have an important role in the c...

This report updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the 2015-16 season includes 1) antigenic composition of U.S. seasonal in...